0DRP.LSE Biohit Oyj
- Market cap
- EUR 38.8M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0DRP.LSE undervalued?
Graham numberThe Graham number of Biohit Oyj cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Biohit Oyj fundamental analysis
No fundamental analysis for Biohit Oyj yet.
Biohit Oyj stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Biohit Oyj
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, …
Full company profileFinancial statements of Biohit Oyj are not available yet.
Biohit Oyj dividends
Biohit Oyj has not paid dividends in the last 4 fiscal years.
Who owns Biohit Oyj
- Insiders 49.08%
- Institutions 0.00%
- Public & others 50.92%
- Shares outstanding 14.9M
- Free float 7.17M
Biohit Oyj company profile
- Company name
- Biohit Oyj
- Ticker
- 0DRP.LSE
- ISIN
- FI0009005482
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 47
- Fiscal year end
- December
- Address
- Laippatie 1, Helsinki, Finland, 00880
- Phone
- 358 9 773 861
- Website
- biohithealthcare.com
About Biohit Oyj
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practitioners in interpreting GastroPanel test results; and GP Reader NT for the quantitative determination of various analytes in human samples. It also provides BIOHIT active B12 (HoloTC) test, BIOHIT total 25OH vitamin D test, and BIOHIT Calprotectin; BIOHIT ColonView quick test for detection of fecal occult blood (FOB) in stool samples; BIOHIT Celiac quick test, a qualitative in vitro immunochromatographic test aiding in diagnosis of celiac disease; BIOHIT H. pylori UFT300 and H.pylori tests for the diagnosis of H,pylori infection; lactose intolerance quick test kit; and Gluten Immunogenic Peptides test. In addition, it offers Acetium acetaldehyde binding products, such as the Acetium lozenge to help quit smoking and Acetium capsule for the protection of the stomach. Further, the company provides monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. Additionally, it offers BIOHIT FAEX sample system for the collection and handling of stool samples. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.
Biohit Oyj management
7- Prof. Osmo Antero Suovaniemi M.D., Ph.D.Founder, Deputy CEO, Member of Scientific Advisory Board & Director · born 1943
- Mr. Jussi HahtelaPresident & CEO · born 1973
- Mr. Jussi SorvoChief Financial Officer · born 1990
- Ms. Kati PiironenChief Technology Officer · born 1991
- Mr. Ville SuovaniemiHead of Global Sales & Marketing
- Mr. Yulia KubachevaHead of Diagnostics Department - Biohit Russia
- Graham Johnson B.Sc.Managing Director of Biohit Healthcare Ltd - UK · born 1977